About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Primary Sjögren Syndrome | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT01989819

Primary Sjögren Syndrome

Primary Sjögren syndrome (pSS) is an inflammatory, autoimmune, multiorgan disease often involving the central and peripheral nervous systems. Fifteen to twenty percent of patients with the primary Sjö...

Lead sponsor: University Hospital, Limoges•7 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

University Hospital, Limoges

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Patients with pSS according to revised European criteria and exhibiting neuropathic pain without any electromyographic abnormality will be included (Group I).
•Age of entry into the study ≥ 18 yrs (both groups).
•Affiliated or profit patient of a social security system (both groups).
•Informed consent signed up (both groups).

Exclusion Criteria

•Chronic alcoholism
•Type I or type II diabetes
•Peripheral neuropathy unrelated to pSS complications
•Coagulation disease
•Previous allergy to xylocaine, lidocaine, prilocaine or ricin oil
•Porphyria, methemoglobinemia
•Patients under measure of maintenance of justice.
•Patients unable to understand or to participate to the study.
•Child and major patients making the object of a measure of lawful protection.
•Patients deprived of freedom.
•Pregnant, nursing women.
•Participation in biomedical research within one month prior to inclusion.

Related studies

COMPLETEDPhase 2

Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome

NCT06203457 · Primary Sjögren's Syndrome

COMPLETEDPhase 1

Safety and Tolerability of IBI355 in Patients With Primary Sjogren's Syndrome

NCT06484855 · Primary Sjögren's Syndrome

COMPLETEDPhase 2

A Study of the Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome (pSS)

NCT05817669 · Primary Sjögren's Syndrome

Not Yet RecruitingPhase 2

Therapeutic Effect of Upadacitinib in Primary Sjögren's Syndrome

NCT06862284 · Primary Sjögren's Syndrome (pSS)

Acupuncture Combined With Hydroxychloroquine

NCT06432101 · Primary Sjögren's Syndrome

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 11, 2019Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment44

Start dateSep 2012

Last updatedJan 11, 2019

Condition

Primary Sjögren's Syndrome

Locations shown

CH d'Albi

Albi

CHU Bordeaux

Bordeaux

CH de Brive

Brive-la-Gaillarde

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 11, 2019Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions